KING INTERNATIONAL INVESTMENT LIMITED King International Investment Limited Stock
Equities
928
KYG5924H1231
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.076 HKD | +8.57% |
|
+2.70% | -7.32% |
| Mar. 19 | King International Investment Limited Announces Management Changes | CI |
| Mar. 14 | King International Investment Limited Announces Change of Joint Company Secretary Andauthorised Representative | CI |
| Sales 2022 | 92.87M 11.86M | Sales 2023 | 224M 28.6M | Capitalization | 146M 18.71M |
|---|---|---|---|---|---|
| Net income 2022 | -34M -4.34M | Net income 2023 | -25M -3.19M | EV / Sales 2022 | 1.28 x |
| Net cash position 2022 | 36.98M 4.72M | Net cash position 2023 | 11.06M 1.41M | EV / Sales 2023 | 0.61 x |
| P/E ratio 2022 |
-4.51
x | P/E ratio 2023 |
-5.56
x | Employees | 31 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 38.64% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +8.57% | ||
| 1 week | +2.70% | ||
| Current month | -1.30% | ||
| 1 month | -1.30% | ||
| 3 months | -24.00% | ||
| 6 months | +13.43% | ||
| Current year | -7.32% |
1 week
0.07
0.08
1 month
0.070.08
Current year
0.070.12
1 year
0.040.13
3 years
0.040.22
5 years
0.040.59
10 years
0.0418.60
| Managers | Title | Age | Since |
|---|---|---|---|
Ming Qing Liu
CEO | Chief Executive Officer | 45 | 23-08-08 |
Ching Yee Shum
DFI | Director of Finance/CFO | 55 | 22-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wai Lun Man
BRD | Director/Board Member | 52 | 19-01-07 |
Ming Qing Liu
CEO | Chief Executive Officer | 45 | 23-08-08 |
Zhen Pang
BRD | Director/Board Member | 48 | 21-12-05 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 0.076 | +8.57% | 464,000 |
| 24-04-25 | 0.07 | 0.00% | 840,000 |
| 24-04-24 | 0.07 | -1.41% | 820,000 |
| 24-04-23 | 0.071 | 0.00% | 660,000 |
| 24-04-22 | 0.071 | -4.05% | 2,956,000 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am EDT
More quotes
King International Investment Ltd, formerly Life Healthcare Group Ltd is an investment holding company principally engaged in health products and services. The Company operates its business through three segments. The Healthcare Products and Services business segment is principally engaged in the provision of genetic testing, health data analysis services and health product trading services. The Sales of Liquor Business segment is principally engaged in the sales of Maotai-flavor liquor and other liquors. The Money Lending Business segment is principally engaged in short-term loan business such as mortgage loans and unmortgage loans.
Calendar
2024-06-27
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -7.32% | 17.96M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- 928 Stock
